Eton Pharmaceuticals Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Eton Pharmaceuticals Stock Summary

Eton Pharmaceuticals competes with Connect Biopharma, Acumen Pharmaceuticals, Nuvation Bio, Eledon Pharmaceuticals, and Eliem Therapeutics. Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois. Eton Pharmaceutcials operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 17 people.

Eton Pharmaceuticals Key Financial Ratios

Eton Pharmaceuticals Key Balance Sheet Accounts

Eton Pharmaceuticals Key Income Statement Accounts

Eton Pharmaceuticals Key Cash Accounts

Eton Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Eton Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Eton Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eton Pharmaceuticals competition to find correlations between indicators driving Eton Pharmaceuticals's intrinsic value. More Info.Eton Pharmaceuticals is rated below average in return on equity category among its peers. It is rated # 2 in return on asset category among its peers . At this time, Eton Pharmaceuticals' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eton Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Eton Pharmaceuticals Systematic Risk

Today, most investors in Eton Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Eton Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Eton Pharmaceuticals growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Eton Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Eton Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Eton Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Eton Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Eton Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eton Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Eton Stock, please use our How to Invest in Eton Pharmaceuticals guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eton Pharmaceuticals. If investors know Eton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eton Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Eton Pharmaceuticals is measured differently than its book value, which is the value of Eton that is recorded on the company's balance sheet. Investors also form their own opinion of Eton Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eton Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eton Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eton Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Eton Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eton Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eton Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.